Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 1;140(5):504-511.
doi: 10.1001/jamaophthalmol.2022.0671.

Rates of Visual Field Change in Patients With Glaucoma and Healthy Individuals: Findings From a Median 25-Year Follow-up

Sara Giammaria  1   2   3 , Donna M Hutchison  1   2 , Paul E Rafuse  1   2 , Lesya M Shuba  1   2 , Raymond P LeBlanc  1   2 , Marcelo T Nicolela  1   2 , Balwantray C Chauhan  1   2
Affiliations

Rates of Visual Field Change in Patients With Glaucoma and Healthy Individuals: Findings From a Median 25-Year Follow-up

Sara Giammaria et al. JAMA Ophthalmol. .

Abstract

Importance: Estimating the rate of glaucomatous visual field change provides practical assessment of disease progression and has implications for management decisions.

Objective: To assess the rates of visual field change in patients receiving treatment for glaucoma compared with healthy individuals over an extensive follow-up period and to quantify the impact of important covariates for these rates.

Design, setting, and participants: This prospective longitudinal cohort study was conducted in a hospital-based setting from January 1991 to February 2020. The study included 40 patients receiving treatment for open-angle glaucoma and 29 healthy participants. One eye of each participant was randomly selected as the study eye.

Exposures: Patients with glaucoma and healthy participants received testing with standard automated perimetry every 6 months. Individual rates of mean sensitivity change were computed using ordinary least-squares regression analysis, and linear mixed-effects modeling was used to estimate the mean rates of mean sensitivity change in the 2 groups and the impact of baseline mean sensitivity, baseline age, and follow-up intraocular pressure for rate estimates.

Main outcomes and measures: Rate of mean sensitivity change in patients with glaucoma and healthy participants.

Results: A total of 40 patients with glaucoma (median age, 53.07 years [IQR, 48.34-57.97 years]; 21 men [52%]) and 29 healthy participants (median age, 48.80 years [IQR, 40.40-59.07 years], 17 women [59%]) were followed up for a median of 25.65 years (IQR, 22.49-27.02 years) and 19.56 years (IQR, 16.19-26.21 years), respectively. Most participants (65 individuals [94%]) self-identified as White, with the exception of 2 patients with glaucoma (1 self-identified as Black and 1 as South Asian) and 2 healthy participants (both self-identified as South Asian). The mean follow-up intraocular pressure of patients with glaucoma (median, 15.83 mm Hg [IQR, 13.05-17.33 mm Hg]) was similar to that of healthy participants (median, 14.94 mm Hg [IQR, 13.28-16.01 mm Hg]; P = .25). In an ordinary least-squares regression analysis, 31 patients (78%) with glaucoma had rates of mean sensitivity change within the range of healthy participants (ie, between -0.20 dB/y and 0.15 dB/y). Linear mixed-effects modeling revealed that the mean (SE) rate of mean sensitivity change in healthy participants was 0.003 (0.033) dB/y (95% CI, -0.062 to 0.068; P = .93). In comparison, patients with glaucoma had a mean (SE) rate of mean sensitivity change that was -0.032 (0.052) dB/y faster, but this difference was not statistically significant (95% CI, -0.134 to 0.070; P = .53). Among covariates, only baseline mean sensitivity was associated with the rate of mean sensitivity change (mean [SE], 0.021 [0.010] dB/y/dB; 95% CI, 0.002-0.041; P = .03).

Conclusions and relevance: The results of this cohort study suggest that over a median follow-up of more than 25 years, the rate of visual field change in patients receiving treatment for glaucoma was comparable to that of healthy individuals. These findings could guide practitioners in making management decisions.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Nicolela reported receiving grants from Allergan and personal fees from Bausch + Lomb Canada and Labtician Théa outside the submitted work. Dr Chauhan reported receiving grants from the Canadian Institutes of Health Research during the conduct of the study. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. Case Examples of Visual Field Mean Sensitivity During Follow-up
Each pointwise visual field sensitivity value obtained using the full-threshold strategy was converted to Swedish interactive thresholding algorithm (SITA) standard-equivalent values using appropriate nomograms to compute mean sensitivity. Full threshold indicates original full-threshold data, converted indicates converted SITA-equivalent values, and SITA indicates actual subsequent SITA test data.
Figure 2.
Figure 2.. Distribution of Follow-up Duration and Number of Visual Field Tests
A total of 40 patients with glaucoma and 29 healthy individuals were included.
Figure 3.
Figure 3.. Distribution of Rates of Visual Field Change
Distribution of rates of mean sensitivity change were computed using ordinary least-squares regression analysis. A total of 40 patients with glaucoma and 29 healthy individuals were included.
See this image and copyright information in PMC

Comment in

References

    1. Chauhan BC, Garway-Heath DF, Goni FJ, et al. . Practical recommendations for measuring rates of visual field change in glaucoma. Br J Ophthalmol. 2008;92(4):569-573. doi:10.1136/bjo.2007.135012 - DOI - PMC - PubMed
    1. Jansonius NM. On the accuracy of measuring rates of visual field change in glaucoma. Br J Ophthalmol. 2010;94(10):1404-1405. doi:10.1136/bjo.2009.164897 - DOI - PubMed
    1. Garway-Heath DF, Quartilho A, Prah P, Crabb DP, Cheng Q, Zhu H. Evaluation of visual field and imaging outcomes for glaucoma clinical trials (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2017;115:T4. - PMC - PubMed
    1. Quigley HA, Friedman DS, Hahn SR. Evaluation of practice patterns for the care of open-angle glaucoma compared with claims data: the Glaucoma Adherence and Persistency Study. Ophthalmology. 2007;114(9):1599-1606. doi:10.1016/j.ophtha.2007.03.042 - DOI - PubMed
    1. Malik R, Baker H, Russell RA, Crabb DP. A survey of attitudes of glaucoma subspecialists in England and Wales to visual field test intervals in relation to NICE guidelines. BMJ Open. 2013;3(5):e002067. doi:10.1136/bmjopen-2012-002067 - DOI - PMC - PubMed

Publication types